{
 "PrintNo":"A5392","Version":"A","Session":2025,"Chamber":"ASSEMBLY","BillType":"Assembly",
 "Published":"2025-02-13T15:43:18.52627Z","Status":"IN_ASSEMBLY_COMM","Committee":"Health",
 "Milestones":[{"Type":"IN_ASSEMBLY_COMM","Date":"2025-05-09","Committee":"Health"}],
 "Actions":[
  {"Text":"REFERRED TO HEALTH","Date":"2025-02-13","Chamber":"ASSEMBLY"},
  {"Text":"AMEND (T) AND RECOMMIT TO HEALTH","Date":"2025-05-09","Chamber":"ASSEMBLY"},
  {"Text":"PRINT NUMBER 5392A","Date":"2025-05-09","Chamber":"ASSEMBLY","Version":"A"}
 ],
 "Sponsors":[{"ID":520,"Name":"Linda Rosenthal","Short":"ROSENTHAL"}],
 "Title":"Expands the definition of epinephrine devices to include epinephrine nasal sprays",
 "Summary":"Defines epinephrine device as a single-use auto-injector device or nasal spray device used for the automatic injection or administration of a premeasured dose of epinephrine into the human body for the purpose of emergency treatment of a person appearing to experience anaphylactic symptoms.",
 "LawSection":"Public Health Law",
 "LawCode":"Amd §§3000-c & 3000-a, Pub Health L; amd §§902-b, 916-a, 921 & 921-a, Ed L",
 "ActClause":"AN ACT to amend the public health law and the education law, in relation to expanding the definition of epinephrine devices to include epinephrine nasal sprays"
}